These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Gregory SM; Harada E; Liang B; Delos SE; White JM; Tamm LK Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11211-6. PubMed ID: 21690393 [TBL] [Abstract][Full Text] [Related]
9. Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution. Beniac DR; Booth TF Sci Rep; 2017 Apr; 7():46374. PubMed ID: 28397863 [TBL] [Abstract][Full Text] [Related]
10. Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage. Bestle D; Bittel L; Werner AD; Kämper L; Dolnik O; Krähling V; Steinmetzer T; Böttcher-Friebertshäuser E Virus Res; 2024 Sep; 347():199430. PubMed ID: 38964470 [TBL] [Abstract][Full Text] [Related]
11. Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement. Vaknin A; Grossman A; Durham ND; Lupovitz I; Goren S; Golani G; Roichman Y; Munro JB; Sorkin R ACS Infect Dis; 2024 May; 10(5):1590-1601. PubMed ID: 38684073 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739 [TBL] [Abstract][Full Text] [Related]
13. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation. Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH mBio; 2020 Sep; 11(5):. PubMed ID: 32934085 [TBL] [Abstract][Full Text] [Related]
14. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger. Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950 [TBL] [Abstract][Full Text] [Related]
15. Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Koellhoffer JF; Chen G; Sandesara RG; Bale S; Saphire EO; Chandran K; Sidhu SS; Lai JR Chembiochem; 2012 Nov; 13(17):2549-57. PubMed ID: 23111988 [TBL] [Abstract][Full Text] [Related]
16. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015 [TBL] [Abstract][Full Text] [Related]
17. Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids. Regula LK; Harris R; Wang F; Higgins CD; Koellhoffer JF; Zhao Y; Chandran K; Gao J; Girvin ME; Lai JR Biochemistry; 2013 May; 52(20):3393-404. PubMed ID: 23650881 [TBL] [Abstract][Full Text] [Related]
18. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Zhao Y; Ren J; Harlos K; Jones DM; Zeltina A; Bowden TA; Padilla-Parra S; Fry EE; Stuart DI Nature; 2016 Jul; 535(7610):169-172. PubMed ID: 27362232 [TBL] [Abstract][Full Text] [Related]
19. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies. Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924 [TBL] [Abstract][Full Text] [Related]
20. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by Mittler E; Alkutkar T; Jangra RK; Chandran K mBio; 2021 Jan; 12(1):. PubMed ID: 33436438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]